This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Guilin Zhang: Innovator in Nucleic Acid Composition
Introduction
Guilin Zhang is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid compositions. His work has implications for various applications, including virus detection and vaccine screening.
Latest Patents
Guilin Zhang holds a patent for an innovative nucleic acid composition related to the expression of recombinant EBIV-related genes and proteins. The patent, titled "EBIV nucleic acid composition and application thereof," discloses a nucleic acid composition that includes sequences shown in SEQ ID NO. 14, 15, 16, and 17. This composition allows for the construction of a recombinant EBIV that exhibits broad-spectrum infectivity to mammalian and mosquito cells. The virus can be stably passaged and features green fluorescence, which aids in research for in vitro and in vivo virus tracing, virus detection, antiviral drugs, and vaccine screening. This invention holds significant application prospects in the field of virology.
Career Highlights
Guilin Zhang has worked with esteemed organizations such as the Chinese Academy of Sciences and Midea Group Co., Ltd. His experience in these institutions has contributed to his expertise in biotechnology and innovation.
Collaborations
Throughout his career, Guilin Zhang has collaborated with notable colleagues, including Han Xia and Fei Wang. These partnerships have fostered a collaborative environment that enhances research and development in his field.
Conclusion
Guilin Zhang is a notable inventor whose work in nucleic acid composition has the potential to advance research in virology and biotechnology. His contributions are paving the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
